Aseptic Conference Provides Solutions to Pharmaceutical Challenges
ISPE
OCTOBER 27, 2022
You will get answers to the following questions: How were the fill-finish processes for the SARS CoV-2 vaccines developed and qualified, and how did the manufacturers manage to provide vaccine doses in such large quantities in such a short time? SARS CoV-2 vaccines have been formulated in lipid nanoparticles.
Let's personalize your content